The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.
Primary Purpose
Stroke, Dehydration
Status
Unknown status
Phase
Phase 2
Locations
Taiwan
Study Type
Interventional
Intervention
water
Sponsored by
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Dehydration, Fluid therapy
Eligibility Criteria
Inclusion Criteria:
- Acute ischemic stroke diagnosed by the clinical presentations and brain imaging is confirmed by a stroke care specialist,
- has a measurable neurologic deficit according to the National Institutes of Health Stroke Scale (NIHSS),
- the time between the onset of neurological symptoms and starting therapy are less than 48 hours,
- admission BUN/Cr<15
Exclusion Criteria:
- no informed consent obtained,
- initial NIHSS >15,
- prepared for or received fibrinolytic therapy,
- prepared for or received surgical intervention with 14 days,
- congestive heart failure according to past history or Framingham criteria,
- history of liver cirrhosis or severe liver dysfunction (ALT or AST > x 3 upper normal limit),
- admission blood Cr >2 mg/dl,
- initial blood pressure SBP<90 mmHg,
- fever with core temperature >=38°C,
- indication of diuretics for fluid overload,
- any conditions needed more aggressive hydration or blood transfusion,
- cancer under treatment,
- life expectancy or any reasons for follow-up < 3 months
Sites / Locations
- Chang Gung Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
urine monitoring group
Arm Description
Patients of urine monitoring group will be checked for urine specific gravity (USG) once between 6a.m. to 12 m.d. in the first 5 days after admission. Patients will be advised to have water according to the level of USG.
Outcomes
Primary Outcome Measures
the rate of post-stroke infection
The post-stroke infection is defined as a core body temperature>38C in any time point.
Secondary Outcome Measures
functional outcome
We use modified Rankin scale for neurological evaluation to assess whether USG based hydration therapy results in clinical benefit at three months.
Full Information
NCT ID
NCT02668848
First Posted
January 27, 2016
Last Updated
June 22, 2017
Sponsor
Chang Gung Memorial Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02668848
Brief Title
The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.
Official Title
The Fluid Therapy Strategy of the Patients With Acute Ischemic Stroke and a Bun/Cr Ratio Less Than 15.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
January 2016 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
February 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators previously found that a blood urea nitrogen/creatinine (BUN/Cr) ratio >15 is an independent predictor of early deterioration after acute ischemic stroke. Another study was conducted to determine whether urine specific gravity, another indicator of hydration status and one more easily obtained, is also an independent predictor of early deterioration or stroke-in-evolution (SIE) in such patients. The investigators also conducted a preliminary study, enrolling ischemic stroke patients with a BUN/Cr ratio >15 and find daily Bun/Cr based hydration help to decrease post stroke infection rate and improve 3 months functional outcome. In this study, daily urine specific gravity will be used to adjust hydration therapy in ischemic stroke patients with initial Bun/Cr ratio <15. The primary outcome is the post stroke infection rate in the first 7 days after admission, and secondary outcome is 3 months functional outcome using mRS.
Detailed Description
Stroke remains a major medical issue. According to the American Heart Association (AHA) report in 2012, a new or recurrent stroke occurs in around 795,000 people each year, and 1 out of every 18 deaths in the United States is due to stroke. The incidence of stroke may be even higher in the Chinese population than in the US population. In Taiwan, the average annual incidence rate of first-ever stroke for people above 36 years is 330 per 100,000. The associated disease burden of stroke is increasing annually and remains a significant health concern. Common medical complications of stroke include infections, falls, pressure sores, and depression. A systematic review showed that 30% of patients develop post-stroke infection. Though rates of pneumonia and urinary tract infection after stroke are both 10%, pneumonia is associated with higher mortality. If stroke patients become infected during admission, they may experience neurologic deterioration, poor functional outcome, and increased length of stay (LOS).
Adequate hydration is necessary for maintenance of physiologic homeostasis. Dehydration is a frequent cause of mortality in elderly patients. Dehydration is a common and early feature of acute ischemic stroke and may be a contributor to poor outcomes. In the absence of known biological markers of dehydration, biochemical data were analyzed to identify such markers. These studies showed that the blood urea nitrogen (BUN)/creatinine (Cr) ratio ≥ 15 can be used as a marker of dehydration. Our previous study also revealed that BUN/Cr ratio ≥ 15 is an independent predictor of stroke-in-evolution (SIE). These studies suggest that BUN/Cr ratio may used to identify those patients with acute ischemic stroke who are dehydrated and will benefit from hydration therapy.
The investigators then conducted a phase II single arm control trial of patients with acute ischemic stroke and BUN/Cr ratio ≥15 conducted from January 2011 to December 2013. The results demonstrated blood urea nitrogen/creatinine (BUN/Cr)-based hydration therapy decreases the length of stay (LOS) and rate of post-stroke infection.
Since the BUN/Cr ratio is an indicator of hydration status, and urine specific gravity is also an indicator of hydration status, the investigators hypothesized that urine specific gravity would also be an independent predictor of early deterioration. A urine specific gravity >1.010 indicates that urine is concentrating in the kidneys which means that the body might be relatively dehydrated. Because such an increase in urine specific gravity occurs earlier than an increase in the BUN/Cr ratio, the investigators thought that an increase in urine specific gravity might be an earlier predictor of early deterioration in ischemic stroke than the BUN/Cr ratio.
In this study, daily urine specific gravity will be used to adjust hydration therapy in ischemic stroke patients with initial Bun/Cr ratio <15. The primary outcome is the post stroke infection rate in the first 7 days after admission, and secondary outcome is 3 months functional outcome using mRS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Dehydration
Keywords
Stroke, Dehydration, Fluid therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
250 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
urine monitoring group
Arm Type
Experimental
Arm Description
Patients of urine monitoring group will be checked for urine specific gravity (USG) once between 6a.m. to 12 m.d. in the first 5 days after admission. Patients will be advised to have water according to the level of USG.
Intervention Type
Dietary Supplement
Intervention Name(s)
water
Intervention Description
If USG>1.02, patients will be advised to drink water via oral or tubal feeding with a dose of 5cc/kg body weight , maximum 300cc, and repeat the same amount of water after dinner in the same day.
Primary Outcome Measure Information:
Title
the rate of post-stroke infection
Description
The post-stroke infection is defined as a core body temperature>38C in any time point.
Time Frame
the first 7 days after admission
Secondary Outcome Measure Information:
Title
functional outcome
Description
We use modified Rankin scale for neurological evaluation to assess whether USG based hydration therapy results in clinical benefit at three months.
Time Frame
3 months after ischemic stroke
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Acute ischemic stroke diagnosed by the clinical presentations and brain imaging is confirmed by a stroke care specialist,
has a measurable neurologic deficit according to the National Institutes of Health Stroke Scale (NIHSS),
the time between the onset of neurological symptoms and starting therapy are less than 48 hours,
admission BUN/Cr<15
Exclusion Criteria:
no informed consent obtained,
initial NIHSS >15,
prepared for or received fibrinolytic therapy,
prepared for or received surgical intervention with 14 days,
congestive heart failure according to past history or Framingham criteria,
history of liver cirrhosis or severe liver dysfunction (ALT or AST > x 3 upper normal limit),
admission blood Cr >2 mg/dl,
initial blood pressure SBP<90 mmHg,
fever with core temperature >=38°C,
indication of diuretics for fluid overload,
any conditions needed more aggressive hydration or blood transfusion,
cancer under treatment,
life expectancy or any reasons for follow-up < 3 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leng C Lin, M.D.
Phone
+886 53621000
Ext
2805
Email
a3456711@ms65.hinet.net
First Name & Middle Initial & Last Name or Official Title & Degree
Jen T Yang, PHD
Phone
+886 975353203
Email
jents716@ms32.hinet.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leng C Lin, M.D.
Organizational Affiliation
Department of Emergency Medicine, Chang Gung Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chang Gung Memorial Hospital
City
Chiayi
ZIP/Postal Code
613
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leng C Lin, MD
Phone
+886 05 3621000
Ext
2805
Email
a3456711@ms65.hinet.net
First Name & Middle Initial & Last Name & Degree
Leng C Lin, MD
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
24768671
Citation
Lin LC, Lee JD, Hung YC, Chang CH, Yang JT. Bun/creatinine ratio-based hydration for preventing stroke-in-evolution after acute ischemic stroke. Am J Emerg Med. 2014 Jul;32(7):709-12. doi: 10.1016/j.ajem.2014.03.045. Epub 2014 Apr 4.
Results Reference
result
PubMed Identifier
26338107
Citation
Lin WC, Shih HM, Lin LC. Preliminary Prospective Study to Assess the Effect of Early Blood Urea Nitrogen/Creatinine Ratio-Based Hydration Therapy on Poststroke Infection Rate and Length of Stay in Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2720-7. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.002. Epub 2015 Aug 31.
Results Reference
result
Learn more about this trial
The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.
We'll reach out to this number within 24 hrs